{
"description": null,
"compose": {
"include": [ {
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept": [ {
"code": "1037042",
"display": "dabigatran etexilate"
}, {
"code": "1114195",
"display": "rivaroxaban"
}, {
"code": "11289",
"display": "Warfarin"
}, {
"code": "1364430",
"display": "apixaban"
}, {
"code": "15202",
"display": "argatroban"
}, {
"code": "321208",
"display": "fondaparinux"
}, {
"code": "5224",
"display": "heparin"
}, {
"code": "67108",
"display": "Enoxaparin"
}, {
"code": "67109",
"display": "Dalteparin"
}, {
"code": "69646",
"display": "tinzaparin"
} ]
} ]
},
"_filename": "ValueSet-2.16.840.1.113762.1.4.1021.9.json",
"package_name": "us.nlm.vsac",
"date": "2017-08-11T01:00:04-04:00",
"meta": {
"profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ],
"versionId": "18",
"lastUpdated": "2023-12-21T17:43:03.000-05:00"
},
"publisher": "TJC EH Steward",
"jurisdiction": [ {
"coding": [ {
"code": "US",
"system": "urn:iso:std:iso:3166"
} ]
} ],
"purpose": "(Clinical Focus: Drugs that specifically inhibit coagulation as independent ingredients for use in noting the most general idea of anticoagulant ingredients. Initial use is for representation of a medication \"not done\". The desire is to have a single choice.),(Data Element Scope: Medication order or discharge NOT DONE),(Inclusion Criteria: Only single ingredient, ingredient-level representation of anticoagulant drugs),(Exclusion Criteria: None)",
"name": "AnticoagulantIngredientSpecific",
"type": null,
"experimental": "false",
"resourceType": "ValueSet",
"expansion": {
"total": 10,
"contains": [ {
"code": "1037042",
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"display": "dabigatran etexilate",
"version": "05062024"
}, {
"code": "1114195",
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"display": "rivaroxaban",
"version": "05062024"
}, {
"code": "11289",
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"display": "warfarin",
"version": "05062024"
}, {
"code": "1364430",
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"display": "apixaban",
"version": "05062024"
}, {
"code": "15202",
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"display": "argatroban",
"version": "05062024"
}, {
"code": "321208",
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"display": "fondaparinux",
"version": "05062024"
}, {
"code": "5224",
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"display": "heparin",
"version": "05062024"
}, {
"code": "67108",
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"display": "enoxaparin",
"version": "05062024"
}, {
"code": "67109",
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"display": "dalteparin",
"version": "05062024"
}, {
"code": "69646",
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"display": "tinzaparin",
"version": "05062024"
} ],
"timestamp": "2024-06-14T09:16:30-04:00",
"identifier": "urn:uuid:b29e339c-38d1-43bf-a287-9f322a8b9ccc"
},
"title": "Anticoagulant ingredient specific",
"package_version": "0.19.0",
"extension": [ {
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueString": "TJC EH Author"
}, {
"url": "http://hl7.org/fhir/StructureDefinition/valueset-keyWord",
"valueString": "Not_In_Use"
}, {
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2024-04-02"
}, {
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2017-08-11"
} ],
"status": "retired",
"id": "e4de8860-03d7-43f1-a4a9-40b179bc6bd0",
"kind": null,
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1021.9",
"identifier": [ {
"value": "urn:oid:2.16.840.1.113762.1.4.1021.9",
"system": "urn:ietf:rfc:3986"
} ],
"version": "20170811"
}